Shares of AbbVie (ABBV) traded 3% higher on Friday morning after the company reported an upbeat first-quarter (Q1) and raised ...

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...

Q1 2025 Management View CEO Bryan DeBoer mentioned that diluted earnings per share for Q1 were $7.94, marking a 34.8% year-over-year increase, with adjusted diluted EPS of $7.66 showing a 25.4% ...

As of the 2025 first quarter, PepsiCo combined its Frito‐Lay and Quaker Foods convenient food businesses into one reporting ...

Wabtec Corporation “started the year strong, delivering over 20% in earnings per share growth and highlighting the continued ...

And $10,000 invested in Nvidia shares in January 2019, then held until today, would be worth about $330,000. And remember, ...

Procter & Gamble's third-quarter results demonstrate slight growth in organic sales and earnings per share, while the company ...

Gabelli expects to report first quarter 2025 diluted earnings in the range of $0.75 to $0.81 per share versus $0.64 per share for the first quarter of 2024. Gabelli will be issuing further details ...

Westinghouse Air Brake Technologies Corp (WAB) reports a 4.5% sales increase and a 21% rise in adjusted EPS, with significant international opportunities and a solid 12-month backlog.